Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone marrow infiltration in neuroblastoma]

B De Bernardi

    La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
    |September 23, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Detecting minimal residual disease in bone marrow for neuroblastoma is crucial. New methods improve detection accuracy, aiding treatment decisions for this challenging childhood cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2016
    Same author

    Congenital neuroblastoma with symptoms of epidural compression at birth.

    Pediatric hematology and oncology·2016
    Same author

    Carcinoid syndrome.

    Pediatric surgery international·2013
    Same author

    Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

    British journal of cancer·2011
    Same author

    Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

    British journal of cancer·2008
    Same author

    Why does neuroblastoma attract us so much?

    Cancer letters·2005

    Area of Science:

    • Pediatric Oncology
    • Hematology
    • Cancer Biology

    Background:

    • Neuroblastoma frequently involves bone marrow at diagnosis, posing treatment challenges.
    • Current methods for detecting minimal residual disease (MRD) post-treatment are insufficient.
    • Bone marrow infiltration is a key prognostic factor in neuroblastoma.

    Discussion:

    • Evaluating the prognostic and therapeutic significance of MRD in neuroblastoma.
    • Comparing novel techniques for sensitive MRD detection in bone marrow.
    • Addressing the limitations of existing diagnostic tools for residual disease.

    Key Insights:

    • Improved methods enhance the detection of minimal residual disease in pediatric neuroblastoma.
    • Accurate MRD assessment is vital for refining treatment strategies.

    Related Experiment Videos

  • Advances in detection offer better prognostic information.

    • Outlook:

    • Potential for earlier detection and more personalized treatment of neuroblastoma.
    • Future research directions in MRD monitoring and its clinical application.
    • Impact of enhanced MRD detection on long-term patient outcomes.